Salicylazosulfapyridine法によるビーグル犬の小腸通過時間の測定
スポンサーリンク
概要
- 論文の詳細を見る
The method for the assessment of small intestinal transit time (SITT) in beagle dogs was investigated by using the time for the first appearance of sulfapyridine in the plasma (TFA) after oral administration of salicylazosulfapyridine (SASP). After administration of SASP into the small intestine or the cecum of anesthetized dogs, sulfapyridine (SP) was detected in the plasma only in the latter case. These results indicate that TFA could be an index of arrival time in the cecum, an index of SITT in dogs. A remarkable inter-individual variation of TFA was observed after oral administration of SASP to fasting dogs, and the mean value of TFA was about 3 h. As for intra-individual variation of TFA, both variable and less variable dogs were observed. TFA was prolonged significantly by atropine (0.1 mg/kg, i.v.) and shortened significantly by metoclopramide (0.5 mg/kg, i.v.). As the pharmacological modification of gastrointestinal motility was thus mirrored by TFA, SASP method is considered to be useful for the assessment of SITT in beagle dogs.
- 社団法人日本薬学会の論文
- 1989-10-25
著者
-
川添 康
吉富製薬株式会社中央研究所
-
小川 建志
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
水田 博彰
吉富製薬株式会社中央研究所
-
小川 建志
吉富製薬株式会社中央研究所
-
芳賀 慶一郎
吉富製薬株式会社中央研究所
-
芳賀 慶一郎
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd.,
-
横部 哲朗
吉富製薬株式会社中央研究所
-
水田 博彰
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
-
水田 博彰
吉富製薬株式会社研究開発本部製剤研究所
-
芳賀 慶一郎
吉富製薬 中研
-
横部 哲朗
Research Laboratories Yoshitomi Pharmaceutical Industries Ltd.
関連論文
- Nitrofurantionの消化管吸収 : イヌにおける消化管通過時間の新規な測定法の有用性評価
- Effect of Small Intestinal Transit Time on Gastrointestinal Absorption of 2-[3-(3,5-Di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethyl Acetate, a New Non-steroidal Anti-inflammatory Agent
- Gastrointestinal Absorption of Chlorothiazide : Evaluation of a Method Using Salicylazosulfapyridine and Acetaminophen as the Marker Compounds for Determination of the Gastrointestinal Transit Time in the Dog
- 新規非ステロイド性抗炎症剤2-[3-(3,5-Di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethyl Acetateの消化管吸収における胆汁の寄与及び食餌の影響
- Effects of Meals on Gastric Emptying and Small Intestinal Transit Times of a Suspension in the Beagle Dog Assessed Using Acetaminophen and Salicylazosulfapyridine as Markers
- Salicylazosulfapyridine法によるビーグル犬の小腸通過時間の測定
- 高速液体クロマトグラフィーによるシステインアルキルエステルの定量
- Utility of Gastrointestinal Physiology Regulated-Dogs : Bioavailability Study of a Commercial sustained-Release Dosage Form of Theophylline
- Gastrointestinal Physiology-Regulated Dogs : Utilization of a Bioavailability Study of a New Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]-diazepine, an Antagonist of Platelet-Activating Factor, and Its Preparations
- Biovavailability Study of Commercial Sustained-Release Preparations of Diclofenac Sodium in Gastrointestinal Physiology Regulated-Dogs
- 新規非ステロイド性抗炎症剤2-[3-(3,5-Di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethyl Acetateの消化管吸収の改善
- Comparative Pharmacokinetics of Sulpiride and N-[(1-Butyl-2-pyrrolidinyl)methyl]-2-methyl-5-sulfamoyl-2,3-dihydrobenzofuran-7-carboxamide Hydrochloride, a New Lipophilic Substituted Benzamide in Rats
- Effect of Gastric Acidity on Bioavailability of N, N-Dimethylcarbamoylmethyl α, 2-Dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate, a New Prodrug-Type Anti-inflammatory Agent
- Gastric pH Profile and Its Control in Fasting Beagle Dogs
- (RS)-7-(2-Aminomethylmorpholino)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acidの結晶水の挙動
- N, N-Dimethylcarbamoylmethyl α, 2-Dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetateと各種添加剤との混合粉砕物の溶出特性とバイオアベイラビリティー
- 新規Thromboxane合成酵素阻害剤Sodium 4-[α-Hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoate(Y-20811)の体内動態(第2報)イヌにおける未変化体及び主代謝物のPharmacokinetics
- 新規Thromboxane合成酵素阻害剤Sodium 4-[α-Hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoate(Y-20811)の体内動態(第1報)イヌにおける尿中代謝物の単離と構造決定
- Powder Coating Mixture of a Novel Anxiolytic, Y-23684 : Dissolution Characteristics and Bioavailability
- Traxanox sodiumの一般薬理作用 I.中枢・体性・自律神経系,消化器系および泌尿・生殖器系に及ぼす影響
- Gastric Acidity-Dependent Bioavailability of Commercial Sustained Release Preparations of Indomethacin, Evaluated by Gastric Acidity-Controlled Beagle Dogs
- 胃酸度調整ビーグル犬を用いたシンナリジンのバイオアベイラビリティーの評価
- Cysteine ethylester hydrochloride(Cystanin®)の生体防御機構に及ぼす影響
- 邦産キノコの成分研究(第8報) : イボテン酸関連化合物のマススペクトル その3 3-Alkoxyisoxazole類のフラグメンテーション
- 邦産キノコの成分研究(第7報) : イボテン酸関連化合物のスママペクトル その2 4-Isoxazolin-3-one類のフラグメンテーション
- Pharmacokinetics and neuroendocrinological studies of bromperidol in schizophrenic patients.